tradingkey.logo
tradingkey.logo
Buscar

Sotera Health Co

SHC
Añadir a la lista de seguimiento
15.565USD
-0.065-0.42%
Horarios del mercado ETCotizaciones retrasadas 15 min
4.44BCap. mercado
37.54P/E TTM

Más Datos de Sotera Health Co Compañía

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Información de Sotera Health Co

Símbolo de cotizaciónSHC
Nombre de la empresaSotera Health Co
Fecha de salida a bolsaNov 20, 2020
Director ejecutivoPetras (Michael B)
Número de empleados3000
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 20
Dirección9100 South Hills Blvd, Suite 300
CiudadBROADVIEW HEIGHTS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal44147
Teléfono14402621410
Sitio Webhttps://soterahealth.com/
Símbolo de cotizaciónSHC
Fecha de salida a bolsaNov 20, 2020
Director ejecutivoPetras (Michael B)

Ejecutivos de Sotera Health Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
125.96K
--
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
80.78K
--
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
80.78K
--
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
39.22K
--
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--
Mr. Constantine S. (Dean) Mihas
Mr. Constantine S. (Dean) Mihas
Independent Director
Independent Director
--
--
Dr. David E. Wheadon, M.D.
Dr. David E. Wheadon, M.D.
Independent Director
Independent Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Independent Director
Independent Director
--
--
Mr. Michael B. Petras, Jr.
Mr. Michael B. Petras, Jr.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
125.96K
--
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
87.30K
+84.29%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
80.78K
--
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
80.78K
--
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
39.22K
--
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: jue., 2 de abr
Divisa: USDActualizado: jue., 2 de abr
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
629.54M
54.10%
Europe
232.18M
19.95%
Canada
221.95M
19.07%
Other
79.95M
6.87%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: hace 15 horas
Actualizado: hace 15 horas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Darsana Capital Partners LP
9.12%
Sculptor Capital Management, Inc
7.36%
Sessa Capital
7.21%
Warburg Pincus LLC
6.70%
BlackRock Institutional Trust Company, N.A.
5.83%
Otro
63.78%
Accionistas
Accionistas
Proporción
Darsana Capital Partners LP
9.12%
Sculptor Capital Management, Inc
7.36%
Sessa Capital
7.21%
Warburg Pincus LLC
6.70%
BlackRock Institutional Trust Company, N.A.
5.83%
Otro
63.78%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
37.40%
Investment Advisor
24.15%
Investment Advisor/Hedge Fund
12.69%
Private Equity
11.16%
Individual Investor
2.32%
Sovereign Wealth Fund
0.90%
Research Firm
0.70%
Pension Fund
0.59%
Bank and Trust
0.32%
Otro
9.77%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
534
269.76M
94.60%
+20.76M
2025Q4
502
227.84M
80.20%
-23.04M
2025Q3
470
259.09M
91.20%
-33.54M
2025Q2
470
278.88M
98.25%
-13.55M
2025Q1
484
279.71M
98.54%
-14.16M
2024Q4
491
273.89M
96.62%
-15.65M
2024Q3
489
274.82M
97.04%
-16.48M
2024Q2
489
271.96M
96.07%
-20.06M
2024Q1
463
270.40M
95.52%
-12.51M
2023Q4
463
265.31M
93.87%
-20.11M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Darsana Capital Partners LP
26.00M
9.14%
+1.00M
+4.00%
Dec 31, 2025
Sculptor Capital Management, Inc
21.00M
7.38%
+7.66M
+57.40%
Dec 31, 2025
Sessa Capital
20.55M
7.23%
+10.63M
+107.17%
Dec 31, 2025
Warburg Pincus LLC
19.10M
6.72%
-15.00M
-43.98%
Mar 06, 2026
BlackRock Institutional Trust Company, N.A.
16.62M
5.84%
+2.78M
+20.08%
Dec 31, 2025
GTCR Golder Rauner, LLC
12.74M
4.48%
-10.00M
-43.98%
Mar 06, 2026
Sachem Head Capital Management LP
11.64M
4.09%
+3.73M
+47.22%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
8.86M
3.12%
-354.20K
-3.84%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: mar., 2 de dic
Actualizado: mar., 2 de dic
Nombre
Proporción
Brandes US Small-Mid Cap Value ETF
1.33%
First Trust Health Care Alphadex Fund
0.92%
Harbor Long-Short Equity ETF
0.56%
Gotham 1000 Value ETF
0.23%
Timothy Plan US Small Cap Core ETF
0.18%
Nuveen ESG Small-Cap ETF
0.16%
BNY Mellon US Small Cap Core Equity ETF
0.12%
WisdomTree US MidCap Fund
0.12%
Strive Small-Cap ETF
0.11%
John Hancock Multifactor Small Cap ETF
0.11%
Ver más
Brandes US Small-Mid Cap Value ETF
Proporción1.33%
First Trust Health Care Alphadex Fund
Proporción0.92%
Harbor Long-Short Equity ETF
Proporción0.56%
Gotham 1000 Value ETF
Proporción0.23%
Timothy Plan US Small Cap Core ETF
Proporción0.18%
Nuveen ESG Small-Cap ETF
Proporción0.16%
BNY Mellon US Small Cap Core Equity ETF
Proporción0.12%
WisdomTree US MidCap Fund
Proporción0.12%
Strive Small-Cap ETF
Proporción0.11%
John Hancock Multifactor Small Cap ETF
Proporción0.11%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI